Elmiron Settlement Conference Scheduled Following Resolution of “Substantial Portion” of Vision Damage Lawsuits
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Nearly 2,000 Elmiron Eye Damage Lawsuits Pending in State and Federal Courts A series of deadlines have been set to prepare the first bellwether Elmiron eye damage lawsuit for trial by late March 2023. November 7, 2022 Irvin Jackson Add Your Comments Johnson & Johnson and its Janssen Pharmaceuticals subsidiary face nearly 2,000 Elmiron eye damage lawsuits pending in federal and state courts nationwide, with the number of claims continuing to raise as the parties prepare for the first “bellwether” trials early next year. Elmiron (pentosan polysulfate sodium) is a prescription medication for treatment of interstitial cystitis or painful bladder syndrome, which is often taken by users for years, since there is no cure of the underlying condition. While the medication was marketed as safe and effective, former users now report that they have been left with a rare form of eye problems from Elmiron, known as pigmentary maculopathy, which results in progressive vision loss, blurry vision, distorted vision, difficulty adapting to dim light and other symptoms from damage to the retina. ELMIRON LAWSUITS Did you or a loved one use Elmiron? Side effects of Elmiron have been linked to vision loss and retinal damage known as pigmentary maculopathy. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ELMIRON LAWSUITS Did you or a loved one use Elmiron? Side effects of Elmiron have been linked to vision loss and retinal damage known as pigmentary maculopathy. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Each of the lawsuits raise similar allegations, indicating Johnson & Johnson and its Janssen Pharmaceuticals subsidiary provided false and misleading information for decades about the Elmiron vision side effects, and failed to warn doctors about the importance of monitoring for vision changes while taking the bladder drug, which can leave users with permanent blurry or distorted vision, as well as blindness. According to a case management order (PDF) issued last month, there are at least 1,926 product liability lawsuits over Elmiron filed and served against the drug makers nationwide, with the vast majority pending in a federal multidistrict litigation (MDL), which has been established before U.S. District Judge Brian R. Martinotti in the District of New Jersey. During a case management conference held on October 12, 2022, Judge Martinotti reviewed the status of the litigation with the parties, and confirmed that the first bellwether trial will begin on March 23, 2023. The parties have also been directed to meet and confer regarding the schedule for two additional claims to go before juries next year. First Elmiron Lawsuit To Impact Settlement Values A complaint (PDF) filed by Maria Windham was selected earlier this year as the first lawsuit to go to trial in the MDL, involving allegations that a Louisiana woman developed retinal pigmentary changes, including macular degeneration, about two years after she started taking Elmiron. Expert discovery has concluded in the case, and a court order (PDF) was issued last week, outline the schedule for challenges to the admissibility of certain evidence and testimony over the next four months. While the outcome of this trial will not be binding on claims brought by other plaintiffs who experienced eye damage, it will be closely watched and is expected to have a large impact on any Elmiron settlement offers the pharmaceutical companies may make to avoid each individual claim being set for trial. Tags: Elmiron, Interstitial Cystitis, Janssen, Johnson & Johnson, Pigmentary Maculopathy, Teva Pharmaceuticals, Vision Loss More Elmiron Lawsuit Stories Elmiron Settlement Conference Scheduled Following Resolution of “Substantial Portion” of Vision Damage Lawsuits January 26, 2024 Elmiron Jury Trial Over Vision Loss Delayed Until March 2023 October 26, 2022 First Elmiron Bellwether Lawsuit On Track For Trial To Begin Jan. 30, 2023 October 4, 2022 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES 6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (Posted: today) A federal judge has identified the six Bard PowerPort lawsuits that will serve as the first bellwether trials, to test allegations that the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCourt Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case (05/06/2025)Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates (04/30/2025)Bard PowerPICC Intravascular Catheter Leaks Linked to Reports of Serious Injuries: FDA (04/21/2025) MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 3 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025) Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: 4 days ago) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)
Elmiron Settlement Conference Scheduled Following Resolution of “Substantial Portion” of Vision Damage Lawsuits January 26, 2024
6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (Posted: today) A federal judge has identified the six Bard PowerPort lawsuits that will serve as the first bellwether trials, to test allegations that the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCourt Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case (05/06/2025)Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates (04/30/2025)Bard PowerPICC Intravascular Catheter Leaks Linked to Reports of Serious Injuries: FDA (04/21/2025)
MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 3 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: 4 days ago) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)